Attention Gainesville Patients: With the LPGA Solheim Cup 2024 coming to the Robert Trent Jones Golf Club in Gainesville, Sept 10-15, please be advised that significant traffic and potential delays are expected in the area. We encourage you to plan your outings accordingly, leaving extra time for travel. Thank you.

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years - Nicholas J. Robert, M.D (Co-Author)

Virginia Cancer Specialists Practice Blog

June 07, 2016
Virginia Cancer Specialists » Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years – Nicholas J. Robert, M.D (Co-Author)

Announcement Virginia Cancer Specialists: Physician Nicholas J. Robert, M.D, featured as co-author in the New England Journal of Medicine

BACKGROUND

Treatment with an aromatase inhibitor for 5 years as up-front monotherapy or after tamoxifen therapy is the treatment of choice for hormone-receptor–positive early breast cancer in postmenopausal women. Extending treatment with an aromatase inhibitor to 10 years may further reduce the risk of breast-cancer re-currence.

Read more here in the New England Journal of Medicine

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More